Abstract
Hypercholesterolemia is a major cardiovascular risk factor regardless of the patient's age. Unfortunately, few studies have been carried out in elderly patients.This lack of evidence does not make it possible to establish strong recommendations for treatment. However, the treatments are as effective and safe as in younger patients. The prescription must therefore be based on the evaluation of the risk-benefit balance between the subject's cardiovascular risk level, their comorbidities, their life expectancy, their functional and cognitive state and their preferences.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
